Rob Carson is a life sciences CEO accelerating biological discovery and drug development. They are the President & CEO and Board Director of Vizgen, a role they assumed in 2024 after leading Ultivue as CEO beginning in May 2023 and overseeing its merger with Vizgen in October 2024. They previously led Orchard Run Capital & Advisory as Managing Member (2021–2023), served as Senior Advisor at iRepertoire (2022–2023), and held board positions with Analytical, Life Science & Diagnostics Association (2019–2021) and RedShiftBio (2019–2021). Earlier in their career, they held executive roles at Waters Corporation in 2019 and a variety of leadership positions at Medtronic (2013–2015), and began their finance career at Bank of America (1996–2000). They earned an MBA from The Wharton School (2000–2002) and a BS from the University of Virginia (1992–1996), and are participating in Harvard Business School Executive Education since 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices